Baker Brothers Advisors - BELLICUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$3,454,000
+22.8%
2,677,8180.0%0.02%
-5.3%
Q3 2019$2,812,000
-38.2%
2,677,8180.0%0.02%
-38.7%
Q2 2019$4,552,000
-49.6%
2,677,8180.0%0.03%
-46.6%
Q1 2019$9,024,000
+15.4%
2,677,8180.0%0.06%
-9.4%
Q4 2018$7,819,000
-52.6%
2,677,8180.0%0.06%
-41.3%
Q3 2018$16,495,000
-45.4%
2,677,818
-34.6%
0.11%
-52.0%
Q2 2018$30,210,000
+10.9%
4,093,447
-1.4%
0.23%
-1.7%
Q1 2018$27,234,000
-35.7%
4,151,578
-17.5%
0.23%
-37.1%
Q4 2017$42,322,000
-27.2%
5,032,3130.0%0.37%
-22.1%
Q3 2017$58,123,000
-1.1%
5,032,3130.0%0.47%
-8.4%
Q2 2017$58,777,000
-5.3%
5,032,3130.0%0.51%
+1.2%
Q1 2017$62,099,000
-6.3%
5,032,313
+3.4%
0.51%
-21.8%
Q4 2016$66,270,000
-31.6%
4,865,6470.0%0.65%
-26.1%
Q3 2016$96,826,000
+53.5%
4,865,6470.0%0.88%
+33.0%
Q2 2016$63,059,000
+38.6%
4,865,6470.0%0.66%
+37.7%
Q1 2016$45,494,000
-53.9%
4,865,6470.0%0.48%
-41.2%
Q4 2015$98,627,000
+62.0%
4,865,647
+16.1%
0.82%
+45.1%
Q3 2015$60,889,000
-31.7%
4,190,5940.0%0.56%
-28.0%
Q2 2015$89,134,000
-8.2%
4,190,5940.0%0.78%
-3.2%
Q1 2015$97,096,000
-1.6%
4,190,594
-2.2%
0.81%
-19.8%
Q4 2014$98,697,0004,283,7321.01%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,051,441$7,760,0001.61%
X-Square Capital, LLC 102,832$759,0000.57%
CORRADO ADVISORS, LLC 78,945$582,0000.35%
Endurant Capital Management LP 71,801$530,0000.23%
Baker Brothers Advisors 4,093,447$30,210,0000.23%
KNOTT DAVID M 76,653$566,0000.21%
L & S Advisors Inc 83,125$613,0000.10%
DAFNA Capital Management LLC 30,000$221,0000.10%
FARALLON CAPITAL MANAGEMENT LLC 2,000,000$14,760,0000.09%
HARVEY CAPITAL MANAGEMENT INC 31,200$230,0000.09%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders